2m 2m 2m 2m 2m 2m 2m
PRECIGEN (PGEN)
NASDAQ
$8.50+$0.29 (+3.54%)
Price as of Oct 02, 2026 5:16 PM EDT- $2.9BMarket Cap
- 146.55%1-Year Change
- BiotechnologyIndustry
PRECIGEN (PGEN)
$8.50+$0.29 (+3.54%)
Earnings Score
Valuation | PGEN | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | -1 | ||
Low Earnings Volatility | 1 |
Momentum Score
Valuation | PGEN | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 20.35% | ||
12-Month Momentum | 105.39% | ||
3-Month Risk Adjusted Momentum | 76.82% | ||
12-Month Risk Adjusted Momentum | 134.79% |
True Yield
Valuation | PGEN | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | -0.03% |
Financial Health Score
Valuation | PGEN | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 2 |